Loading company…
Shanghai-based Shanghai Lide Biotech, established in 2011, provides translational medicine and drug development services.
Based in Shanghai, China, and established in 2011, Shanghai Lide Biotech Co., Ltd. helps pharmaceutical companies develop and screen new drugs, drawing on 12 years of oncology translational research. Its products include Patient Derived Xenograft models, Conditionally Reprogrammed cell lines and MiniPDX in-vivo 3D organoids. The company was listed on the New Third Board with stock code 838848 in August 2016 and received strategic investment of CNY 25 million in July 2017.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in